Home » Newsletters » BioWorld Science

BioWorld Science

March 1, 2017

View Archived Issues

ATYR-1940 granted U.S. orphan drug designation for the treatment of limb girdle muscular dystrophy

FDA grants orphan drug designation to ustekinumab for the treatment of pediatric ulcerative colitis

EMA committee hands down positive opinion for 8-week regimen of Viekirax + Exviera

FDA requests additional information to complete IND review for Titan's ropinirole implant

FDA awards fast track designation to Immunopulse IL-12 for metastatic melanoma

WHO publishes list of antibiotic-resistant priority pathogens

Sanofi seeks Japanese approval for dupilumab for atopic dermatitis

FDA grants rare pediatric disease designation to SB-318 for MPS I

Phase III pediatric study of Latuda for bipolar I depression meets primary endpoint

Immune Pharmaceuticals broadens enrollment criteria in bullous pemphigoid study of bertilimumab

Accera announces results from phase III study of AC-1204 for mild to moderate Alzheimer's disease

Bremelanotide improves desire and distress in hypoactive sexual desire disorder

miR-223 found to play a role in alcoholic liver disease

Astellas and Affinivax enter worldwide partnership for MAPS vaccine targeting pneumococcus

Vycellix and Moffitt Cancer Center establish collaborative research agreement

TGFB2 has a pathogenic role in Alzheimer's disease and dementia with Lewy bodies

Cancer Research UK and HitGen announce license agreement in lung cancer

Kevzara becomes available in Canada

Immunologic responses seen with vesigenurtucel-L in non-muscle invasive bladder cancer

FDA grants priority review to avelumab BLA for metastatic urothelial carcinoma

Johnson & Johnson completes acquisition of Abbott Medical Optics

Perrigo signs agreement to divest Tysabri royalty stream

FDA approves Xermelo for carcinoid syndrome diarrhea

ZUMA-1 study of axicabtagene ciloleucel meets primary endpoint of objective response rate

FDA accepts Dynavax's response to Heplisav-B complete response letter

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...